Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1173 Results

Title
Intervention Indication Therapeutic Area Year Actions
PV-10 for Locally Advanced Cutaneous Melanoma PV-10 (rose bengal sodium) Melanoma Skin Cancer 2018 View  |  Download
PXT3003 for Charcot-Marie-Tooth Disease Type 1A PXT-3003 (fixed dose combination: baclofen; Naltrexone hydrochloride; sorbitol) Charcot-Marie-Tooth disease Genetic Disorders , Neurology 2018 View  |  Download
PXT3003 for treating Charcot-Marie-Tooth disease type 1A PXT-3003 (fixed dose combination: baclofen; Naltrexone hydrochloride; sorbitol) Charcot-Marie-Tooth disease Genetic Disorders , Neurology 2023 View  |  Download
Pylera with omeprazole for treating helicobacter pylori associated ulcers Omeprazole (Yosprala;PA32540;Omeprazole magnesium;Omeprazole sodium , Pylera (BLI-1300;FP-110;Metronidazole benzoate) Helicobacter pylori Gastroenterology 2023 View  |  Download
Quizartinib with chemotherapy for FLT3-ITD positive acute myeloid leukaemia Quizartinib (AC220) Acute myeloid leukaemia (AML) Haematological Cancer and Lymphomas 2021 View  |  Download
rAAVrh74.MHCK7.micro-dystrophin for Duchenne muscular dystrophy Microdystrophin (SRP-9001; rAAVrh74.MHCK7) Duchenne muscular dystrophy (DMD) Genetic Disorders , Musculoskeletal System 2020 View  |  Download
Ramucirumab (Cyramza) + capecitabine or 5-FU + cisplatin for gastric cancer of GOJ – treatment naive for palliative chemotherapy 5-Fluorouracil , Capecitabine (Xeloda) , Cisplatin (Platinol) , Ramucirumab (Cyramza) Gastro-oesophageal junction cancer Gastrointestinal Cancer 2017 View  |  Download
Ramucirumab for Advanced Hepatocellular Carcinoma – second line Ramucirumab (Cyramza) Hepatocellular carcinoma (HCC) Gastrointestinal Cancer 2018 View  |  Download
Ramucirumab in addition to erlotinib for EGFR mutation-positive metastatic non-small-cell lung cancer Erlotinib (Tarceva; erlotinib hydrochloride) , Ramucirumab (Cyramza) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2019 View  |  Download
Ranibizumab Biosimilar for Age-related Macular Degeneration Ranibizumab biosimilar (FYB201; BI695511; PF582; QL1205; Xlucane; SB11) Age-related macular degeneration (AMD) Ophthalmology 2021 View  |  Download
1 2 84 85 86 87 88 117 118
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications